glp-1 obesity drug supply news today New Guidelines on Drugs for Released Obesity GLP-1 Market

The researchers found possible signals that GLP-1 drugs might reduce the risk of some serious infections and offer benefits for lung health, bone outcomes and dementia-related pathways

But as youll hear tonight, breakthroughs like these are anything but overnight. The drugs such as Ozempic and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide) are transforming healthcare

While patches appear cheaper upfront ($15-89/month), prescription GLP-1 medications deliver far superior results and may be covered by insurance, making them more cost-effective for actual weight management

doi:10.2471/B09474

They can both help patients lose a considerable amount of weight and drastically improve health outcomes in various ways

Any microdosing should be done under supervision with your provider and appropriate lab work, says DeGore